Research Using the NACC Database


Medication Use in Frontotemporal Lobar Degeneration (FTLD) as compared to 
Alzheimers Disease (AD)
 
   Lead Investigator:    Adam Boxer
   Institution      :    University of California, San Francisco
   E-Mail           :    aboxer@memory.ucsf.edu
   Proposal ID      :    9

Publications:
1 Tartaglia MC, Hu B, Mehta K, Neuhaus J, Yaffe K, Miller BL, Boxer A Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer's disease Journal Article Alzheimer Dis Assoc Disord,28:182-189,2014,PMC3938980
PUBLISHED

2 Tartaglia MC, Mehta KM, Hu B, Miller BL, Boxer AL Medication Use Differs in Alzheimer's disease and Frontotemporal dementia Abstract Alzheimers and Dementia,6:S589-S590,2010,
PUBLISHED

Proposal Description:
  • rss icon
  • twitter icon
  • facebook icon

NACC is funded by the National Institute on Aging (UO1 AG016976) and located in the Department of Epidemiology at the University of Washington School of Public Health, Walter A. Kukull, Ph.D., Director. Copyright© 2010 University of Washington.